AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,213 | +33.8% | 379 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $10,620 | -3.5% | 379 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $11,000 | -35.3% | 379 | -20.9% | 0.00% | -33.3% |
| Q2 2022 | $17,000 | +6.2% | 479 | +10.9% | 0.00% | +50.0% |
| Q1 2022 | $16,000 | +77.8% | 432 | +14.0% | 0.00% | +100.0% |
| Q4 2021 | $9,000 | +28.6% | 379 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $7,000 | -12.5% | 379 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $8,000 | +14.3% | 379 | 0.0% | 0.00% | -66.7% |
| Q1 2021 | $7,000 | +75.0% | 379 | +96.4% | 0.00% | +50.0% |
| Q3 2019 | $4,000 | -33.3% | 193 | -29.0% | 0.00% | -33.3% |
| Q2 2019 | $6,000 | 0.0% | 272 | -12.8% | 0.00% | 0.0% |
| Q1 2019 | $6,000 | -14.3% | 312 | -6.6% | 0.00% | 0.0% |
| Q4 2018 | $7,000 | 0.0% | 334 | -3.5% | 0.00% | 0.0% |
| Q3 2018 | $7,000 | +75.0% | 346 | +20.6% | 0.00% | +50.0% |
| Q2 2018 | $4,000 | – | 287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 128,000 | $5,886,720 | 5.78% |
| Beacon Harbor Wealth Advisors, Inc. | 103,095 | $4,741 | 1.58% |
| Capital Impact Advisors, LLC | 15,304 | $703,831 | 1.18% |
| Quantedge Capital Pte Ltd | 36,389 | $1,673,530 | 0.91% |
| Mesirow Institutional Investment Management, Inc. | 183,805 | $8,453,192 | 0.86% |
| Monashee Investment Management LLC | 39,461 | $1,814,811 | 0.76% |
| OBERWEIS ASSET MANAGEMENT INC/ | 152,500 | $7,013,475 | 0.74% |
| Granite Investment Partners, LLC | 330,911 | $15,218,597 | 0.64% |
| Portolan Capital Management | 132,850 | $6,109,772 | 0.57% |
| SHAKER INVESTMENTS LLC/OH | 20,795 | $956,362 | 0.53% |